WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , 

ISSN 2457-0400

Impact Factor  :  6.711

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • .

    6th INTERNATIONAL CONFERENCE ON EDUCATIONAL TECHNOLOGY AND CURRICULUM STUDIES(ICETC2019) 

     

    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2023 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

  • WJAHR: MARCH ISSUE PUBLISHED

    March 2024 Issue has been successfully launched on 1 March 2024.

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

SPECTRUM OF ANTIRETROVIRAL (ART) REGIMEN CHANGE AND CONTRIBUTING FACTOR AMONG ADULT HIV/AIDS PATIENT AT SHAMBU HOSPITAL, SHAMBU TOWN, HORRO GUDURU WOLLEGA ZONE, OROMIA REGIONAL STATE, ETHIOPIA

Dinka Dugassa*

ABSTRACT

Background: Human Immune Virus (HIV) is responsible for a worldwide pandemic and it is the cause of Acquired Immune Deficiency Syndrome (AIDS). According to latest statistics 33.4 million individuals worldwide are living with HIV, of which 15.7 million (47%) are women and 2.1 million (6.3%) are children under 15 years. In addition there are 2.7 million new infections and 2.0 million deaths from AIDS worldwide. Result and Conclusion: Patients that changed their regimen were included in the study to identify the reasons for change and descriptive statistics were generated by Using SPSS & using excels for figures. Out of patients, % were females and % were in the age group -. % were WHO clinical stage III patients and % of patients had missed their CD4 count. In % of patients initial treatment regimen was modified after six months, while, in % and % of patient’s initial regimen was modified less than a month and within two to three month time respectively, the most common initial regimens were D4T/3TC/NVP (%), AZT/3TC/NVP (%) and D4T/3TC/EFV (%) The main reasons for modification of therapy were toxicity (%), new drug (%), treatment failure (%), new TB (%), stock out (%), and pregnancy (%) respectively. The main toxicity observed was peripheral neuropathy (%) followed by rash (%) and anemia (%). Among toxicities observed % were due to D4T/3TC/NVP, and the remaining %, %, %, %, % and % were due to AZT/3TC/NVP, D4T/3TC/EFV, AZT/3TC/EFV, TDF/3TC/EFV, TDF/3TC/NVP, and TDF/3TC/LPVr respectively. D4T containing regimens accounted for % of the peripheral neuropathy observed, while NVP containing regimens accounted for % of the rashes reported and AZT containing regimens accounted for % of the Anemia observed. Toxicity was the main reason for initial regimen modification, D4T based regimens had high incidence of peripheral neuropathy. Objective: To determine the reason and contributing factors of anti-retroviral regimen changes among patients on anti-retroviral therapy in ART clinic of Shambu Hospital. Method: A retrospective cross-sectional study was done using patient information sheet and physician diagnosis card from January 1, 2008 to December 31, 2016.

[Full Text Article] [Download Certificate]